Keith William Wegmann from Estancia, NM, age 69

Keith Wegmann Phones & Addresses

Estancia, NM
15916 40Th St, Vancouver, WA 98682 • 3602561656
Hanover, NH
Boscawen, NH
15916 NE 40Th St, Vancouver, WA 98682

Work

Company:

Pvmc
Oct 2005
Position:

Research biologist

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

Washington State University
1979 to 1985
Specialities:

Philosophy, Immunology

Skills

Cell Biology • Research • Microbiology • Microsoft Office • Flow Cytometry • Cellular Immunology • Autoimmune Diseases • Peptide Synthesis • Peptide Design • Multiple Antigenic Peptide • T Cell Epitopes • T Cell Culture • Elisa • Elispot • Teaching • Intracellular Cytokine Staining • Ctl Assays • Graphpad Prism

Emails

w***[email protected]

Industries

Research

Resumes

Research Biologist

view source

Location:

Vancouver, WA

Industry:

Research

Work:

Pvmc
Research Biologist
Portland Providece Medical Center Nov 2004 - Oct 2005
Research Scientist
Portland Va Research Foundation Inc 1995 - 2005
Research Scientist
Ohsu | Oregon Health & Science University 1996 - 2004
Research Assistant Professor, Department of Neurology
Dartmouth-Hitchcock 1994 - 1995
Research Assistant, Department of Surgery

Education:

Washington State University 1979 - 1985
Doctorates, Doctor of Philosophy, Philosophy, Immunology Purdue University 1973 - 1977
Bachelors, Bachelor of Science, Microbiology Washiington State University
Doctorates, Doctor of Philosophy, Microbiology, Immunology

Skills:

Cell Biology
Research
Microbiology
Microsoft Office
Flow Cytometry
Cellular Immunology
Autoimmune Diseases
Peptide Synthesis
Peptide Design
Multiple Antigenic Peptide
T Cell Epitopes
T Cell Culture
Elisa
Elispot
Teaching
Intracellular Cytokine Staining
Ctl Assays
Graphpad Prism

Us Patents

Tr3-Specific Binding Agents And Methods For Their Use
view source
US Patent:

20050282223, Dec 22, 2005
Filed:

Aug 4, 2005
Appl. No.:

11/196919
Inventors:

Thomas Tittle - Portland OR, US
Keith Wegmann - Vancouver WA, US
International Classification:

C12Q001/70
C12Q001/68
US Classification:

435006000, 435005000
Abstract:

Biologically active TR3-specific binding agents and methods for their use are disclosed. The biologically active TR3-specific binding agents are useful for inhibiting the proliferation of cells expressing TR3. These biologically active agents are particularly useful for treating T-cell mediated diseases such as graft-versus-host disease, organ rejection, tumor growth, autoimmunity, and inflammation.

Utilization Of Mhc Class Ii Binding Motifs In Immunization To Produce Immune, Serum, Monoclonal Antibodies And Vaccines
view source
US Patent:

20060013822, Jan 19, 2006
Filed:

Mar 21, 2003
Appl. No.:

10/512325
Inventors:

Thomas Tittle - Portland OR, US
Keith Wegmann - Vancouver WA, US
International Classification:

A61K 39/00
C12Q 1/68
C07H 21/04
C12P 21/06
C07K 14/74
US Classification:

424185100, 435006000, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:

This invention provides compositions and methods for raising humoral antibody responses. The compositions are peptides containing major histocompatibility Class 11 antigen binding motifs (ABM) either native or inserted into the peptide sequence. The ABM can be at the carboxy or amino terminus of the peptide and is shown to provide a T cell epitope thereby assuring adequate T cell help. Associated with the ABM is an extended peptide that rests outside the Class 11 molecule and that is recognized by the B cell, a B cell epitope. This B cell epitope can be a contiguous peptide sequence either at the amino or carboxy terminus. The extended peptide can be irrelevant and can serve as a bridge to an attached B cell epitope such as a hapten. These haptens can be any chemical structure such as a fluorescein molecule or a carbohydrate. The compositions and methods of this invention provide inexpensive vaccines to raise antibodies.

Tr3-Specific Binding Agents And Methods For Their Use
view source
US Patent:

6994976, Feb 7, 2006
Filed:

Nov 17, 2000
Appl. No.:

10/204419
Inventors:

Thomas V. Tittle - Portland OR, US
Keith W. Wegmann - Vancouver WA, US
International Classification:

G01N 33/53
G01N 33/567
C07K 16/00
A61K 38/00
US Classification:

435 71, 435 721, 435 723, 435 724, 5303871, 5303881, 5303891, 514 2
Abstract:

Biologically active TR3-specific binding agents and methods for their use are disclosed. The biologically active TR3-specific binding agents are useful for inhibiting the proliferation of cells expressing TR3. These biologically active agents are particularly useful for treating T-cell mediated diseases such as graft-versus-host disease, organ rejection, tumor growth, autoimmunity, and inflammation.

Keith William Wegmann